105 related articles for article (PubMed ID: 38942527)
1. Decoding Gray Matter Involvement in Multiple Sclerosis via Imaging.
Zivadinov R; Schweser F; Jakimovski D; Bergsland N; Dwyer MG
Neuroimaging Clin N Am; 2024 Aug; 34(3):453-468. PubMed ID: 38942527
[TBL] [Abstract][Full Text] [Related]
2. Detection of Cortical and Deep Gray Matter Lesions in Multiple Sclerosis Using DIR and FLAIR at 3T.
Park CC; Thongkham DW; Sadigh G; Saindane AM; Chu R; Bakshi R; Allen JW; Hu R
J Neuroimaging; 2021 Mar; 31(2):408-414. PubMed ID: 33351983
[TBL] [Abstract][Full Text] [Related]
3. Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.
Pontillo G; Cocozza S; Lanzillo R; Russo C; Stasi MD; Paolella C; Vola EA; Criscuolo C; Borrelli P; Palma G; Tedeschi E; Morra VB; Elefante A; Brunetti A
AJNR Am J Neuroradiol; 2019 Jan; 40(1):99-106. PubMed ID: 30573464
[TBL] [Abstract][Full Text] [Related]
4. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
Steenwijk MD; Daams M; Pouwels PJ; J Balk L; Tewarie PK; Geurts JJ; Barkhof F; Vrenken H
Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545
[TBL] [Abstract][Full Text] [Related]
5. Deep gray matter volume loss drives disability worsening in multiple sclerosis.
Eshaghi A; Prados F; Brownlee WJ; Altmann DR; Tur C; Cardoso MJ; De Angelis F; van de Pavert SH; Cawley N; De Stefano N; Stromillo ML; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Vrenken H; Leurs CE; Killestein J; Pirpamer L; Enzinger C; Ourselin S; Wheeler-Kingshott CAMG; Chard D; Thompson AJ; Alexander DC; Barkhof F; Ciccarelli O;
Ann Neurol; 2018 Feb; 83(2):210-222. PubMed ID: 29331092
[TBL] [Abstract][Full Text] [Related]
6. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.
Xiang B; Wen J; Cross AH; Yablonskiy DA
J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934
[TBL] [Abstract][Full Text] [Related]
7. Association of volumetric MRI measures and disability in MS patients of the same age: Descriptions from a birth year cohort.
de Ruiter LRJ; Loonstra FC; Jelgerhuis JR; Coerver EME; Toorop AA; van Leeuwen ICE; Noteboom S; Moraal B; Strijbis EMM; Schoonheim MM; Uitdehaag BMJ
Mult Scler Relat Disord; 2023 Mar; 71():104568. PubMed ID: 36805177
[TBL] [Abstract][Full Text] [Related]
8. Cortical Gray Matter MR Imaging in Multiple Sclerosis.
Calabrese M; Castellaro M
Neuroimaging Clin N Am; 2017 May; 27(2):301-312. PubMed ID: 28391788
[TBL] [Abstract][Full Text] [Related]
9. Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume.
Harrison DM; Wang KY; Fiol J; Naunton K; Royal W; Hua J; Izbudak I
J Neuroimaging; 2017 Sep; 27(5):461-468. PubMed ID: 28464368
[TBL] [Abstract][Full Text] [Related]
10. Voxel-Based quantitative MRI reveals spatial patterns of grey matter alteration in multiple sclerosis.
Lommers E; Guillemin C; Reuter G; Fouarge E; Delrue G; Collette F; Degueldre C; Balteau E; Maquet P; Phillips C
Hum Brain Mapp; 2021 Mar; 42(4):1003-1012. PubMed ID: 33155763
[TBL] [Abstract][Full Text] [Related]
11. Iron-Insensitive Quantitative Assessment of Subcortical Gray Matter Demyelination in Multiple Sclerosis Using the Macromolecular Proton Fraction.
Yarnykh VL; Krutenkova EP; Aitmagambetova G; Repovic P; Mayadev A; Qian P; Jung Henson LK; Gangadharan B; Bowen JD
AJNR Am J Neuroradiol; 2018 Apr; 39(4):618-625. PubMed ID: 29439122
[TBL] [Abstract][Full Text] [Related]
12. Tissue damage detected by quantitative gradient echo MRI correlates with clinical progression in non-relapsing progressive MS.
Xiang B; Brier MR; Kanthamneni M; Wen J; Snyder AZ; Yablonskiy DA; Cross AH
Mult Scler; 2022 Sep; 28(10):1515-1525. PubMed ID: 35196933
[TBL] [Abstract][Full Text] [Related]
13. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
[TBL] [Abstract][Full Text] [Related]
14. Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study.
Jakimovski D; Kuhle J; Ramanathan M; Barro C; Tomic D; Hagemeier J; Kropshofer H; Bergsland N; Leppert D; Dwyer MG; Michalak Z; Benedict RHB; Weinstock-Guttman B; Zivadinov R
Ann Clin Transl Neurol; 2019 Sep; 6(9):1757-1770. PubMed ID: 31437387
[TBL] [Abstract][Full Text] [Related]
15. Cognitive Implications of Deep Gray Matter Iron in Multiple Sclerosis.
Fujiwara E; Kmech JA; Cobzas D; Sun H; Seres P; Blevins G; Wilman AH
AJNR Am J Neuroradiol; 2017 May; 38(5):942-948. PubMed ID: 28232497
[TBL] [Abstract][Full Text] [Related]
16. Unraveling Deep Gray Matter Atrophy and Iron and Myelin Changes in Multiple Sclerosis.
Pontillo G; Petracca M; Monti S; Quarantelli M; Criscuolo C; Lanzillo R; Tedeschi E; Elefante A; Brescia Morra V; Brunetti A; Cocozza S; Palma G
AJNR Am J Neuroradiol; 2021 Jul; 42(7):1223-1230. PubMed ID: 33888456
[TBL] [Abstract][Full Text] [Related]
17. Enlarged choroid plexus in multiple sclerosis is associated with increased lesion load and atrophy in white matter but not gray matter atrophy.
Akaishi T; Fujimori J; Nakashima I
Mult Scler Relat Disord; 2024 Feb; 82():105424. PubMed ID: 38181695
[TBL] [Abstract][Full Text] [Related]
18. Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis.
Jonkman LE; Fleysher L; Steenwijk MD; Koeleman JA; de Snoo TP; Barkhof F; Inglese M; Geurts JJ
Mult Scler; 2016 Sep; 22(10):1306-14. PubMed ID: 26672996
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo MR microscopy of a human brain with multiple sclerosis: Visualizing individual cells in tissue using intrinsic iron.
Nair G; Dodd S; Ha SK; Koretsky AP; Reich DS
Neuroimage; 2020 Dec; 223():117285. PubMed ID: 32828923
[TBL] [Abstract][Full Text] [Related]
20. Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course.
Cortese R; Battaglini M; Parodi F; Stromillo ML; Portaccio E; Razzolini L; Giorgio A; Sormani MP; Amato MP; De Stefano N
Mult Scler; 2022 Jan; 28(1):154-159. PubMed ID: 34100326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
